Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(43 sites)
United States
Mayo Clinic Hospital, Phoenix, Arizona Mayo Clinic, Scottsdale, Arizona City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California IP Address: City of Hope Investigational Drug Services(IDS), Duarte, California University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora, Colorado